8 Antiphospholipid antibodies: Specificity and pathophysiology
- 1 September 1993
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 6 (3) , 691-709
- https://doi.org/10.1016/s0950-3536(05)80194-5
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Molecular definition of human β2-glycoprotein (α2-GPI) by cDNA cloning and inter-species differences of β2-GPI in alternation of anticardiolipin bindingInternational Immunology, 1991
- Molecular cloning and mammalian expression of human β2‐glycoprotein I cDNAFEBS Letters, 1991
- Risk factors for thrombosis in lupus patients.Annals of the Rheumatic Diseases, 1989
- Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene columnBiochemical and Biophysical Research Communications, 1988
- Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.Annals of the Rheumatic Diseases, 1988
- β2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregationAtherosclerosis, 1987
- Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteinsImmunology Today, 1986
- The Regulation of Hemostasis: The Protein C SystemNew England Journal of Medicine, 1986
- Anticardiolipin antibodies in autoimmune thrombocytopenic purpuraBritish Journal of Haematology, 1985
- LUPUS ANTICOAGULANT AND THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1984